zydelig
gilead sciences ireland uc - idelalisib - lymphoma, non-hodgkin; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, other antineoplastic agents - zydelig is indicated in combination with an anti‑cd20 monoclonal antibody (rituximab or ofatumumab) for the treatment of adult patients with chronic lymphocytic leukaemia (cll):who have received at least one prior therapy, oras first line treatment in the presence of 17p deletion or tp53 mutation in patients who are not eligible for any other therapies. zydelig is indicated as monotherapy for the treatment of adult patients with follicular lymphoma (fl) that is refractory to two prior lines of treatment.
posaconazole msn 300 mg koncentrátum oldatos infúzióhoz
accord healthcare polska sp. z o.o. - posaconazol -
minilip 600 mg filmtabletta
teva magyarország zrt. - a gemfibrozil -
maviret
abbvie deutschland gmbh co. kg - glecaprevir, pibrentasvir - hepatitis c, krónikus - vírusellenes szerek szisztémás alkalmazásra - maviret is indicated for the treatment of chronic hepatitis c virus (hcv) infection in adults and children aged 3 years and older. maviret coated granules is indicated for the treatment of chronic hepatitis c virus (hcv) infection in children 3 years and older.
clarithromycin grünenthal 125 mg granulátum belsőleges szuszpenzióhoz
grünenthal gmbh - klaritromicin -
clarithromycin grünenthal 187,5 mg granulátum belsőleges szuszpenzióhoz
grünenthal gmbh - klaritromicin -
clarithromycin grünenthal 250 mg granulátum belsőleges szuszpenzióhoz
grünenthal gmbh - klaritromicin -
clarosip 125 mg granulátum belsőleges szuszpenzióhoz
grünenthal gmbh - klaritromicin -
clarosip 187,5 mg granulátum belsőleges szuszpenzióhoz
grünenthal gmbh - klaritromicin -
clarosip 250 mg granulátum belsőleges szuszpenzióhoz
grünenthal gmbh - klaritromicin -